Society for Endocrinology - a world-leading authority on hormones

Nastech Pharmaceutical Company Inc. (NSTK) Completes Enrollment of Phase 2 Clinical Trial of PYY3-36 Nasal Spray to Treat Obesity (BioSpace, 8 January 2008)

14 Jan 2008


Nastech Pharmaceutical Company Inc. have completed the enrollment for its Phase 2 clinical trial of PYY3-36 Nasal Spray to treat obesity.

Full article